NZOZ Vivamed Jadwiga Miecz
- Address
- ul. Zamiejska 17, 03-580 Warsaw, Poland
Bacterial Infections and Mycoses
At NZOZ Vivamed Jadwiga Miecz the gastroenterology team is focused on combating Clostridioides difficile infection through innovative prevention strategies.
- Evaluation of recurrence rates with novel microbiome therapy
- Placebo‑controlled studies to assess safety and efficacy
The research aims to reduce infection recurrence and improve patient outcomes, positioning the site as a leader in bacterial infection clinical research in Warsaw.
Immune System Diseases
The department investigates advanced treatments for moderately to severely active ulcerative colitis, exploring the benefits of combined biologic therapy.
- Combination of two biologics to enhance remission rates
- Long‑term safety monitoring of dual‑target approach
By testing the synergy of guselkumab and golimumab, the site seeks to expand therapeutic options for patients with inflammatory bowel disease.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1Vedanta Biosciences Inc.1active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 1 624 other sites in Poland
Therapeutic Area Benchmark — Poland
Select a therapeutic area to compare against other sites in Poland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Poland
Market Share
Country: Poland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in NZOZ Vivamed Jadwiga Miecz
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of Guselkumab and Golimumab Combination Therapy Efficacy and Safety in Moderate to Severe Ulcerative Colitis: A Phase 2b Randomized Controlled Trial | Janssen Cilag International | Phase II | Not Recruiting | Nov 2022 | — |
IMP list
lock Showing 1 of 10 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Bacilli, Cluster Xvii, Strain Relative Clostridium_Aq Innocuum, Live | 1 | Unknown | 2024-10-31 | 2024-10-31 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.